Teladoc Health to Announce First Quarter 2026 Financial Results
Rhea-AI Summary
Teladoc Health (NYSE: TDOC) will release first quarter 2026 financial results on April 29, 2026 after the market close and will host a conference call at 5:00 p.m. ET that day.
The call offers a live audio webcast, international dial‑ins using conference ID 2214924, and a replay that will remain available for approximately 90 days.
Positive
- None.
Negative
- None.
News Market Reaction – TDOC
In the Apr 16 session, TDOC gained 5.05%, reflecting a notable positive market reaction. Our momentum scanner triggered 10 alerts that day, indicating notable trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 05 | Earnings date announcement | Neutral | +5.9% | Set date and call details for Q4 2025 results release. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
The last earnings date announcement on Feb 5, 2026 was followed by a 5.92% gain over 24 hours, indicating prior sensitivity to scheduling earnings releases.
Over the past few months, Teladoc has mixed corporate updates with financial milestones. The company last issued an earnings date release on Feb 5, 2026, ahead of its fourth quarter 2025 report, which coincided with a 5.92% price move. Subsequent earnings on Feb 25, 2026 showed flat Q4 2025 revenue and a full‑year net loss but a strong 15.05% reaction, while board changes in February and March also drew positive responses. Today’s first quarter 2026 earnings date fits this pattern of news-linked trading interest.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release first quarter 2026 results on Wednesday, April 29, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day.
Conference Call Details
The conference call can be accessed by dialing (800) 715-9871 for U.S. participants and using the conference ID # 2214924.
For international participants, please visit the following link for global dial-in numbers, using the same conference ID # 2214924: https://registrations.events/directory/international/itfs.html. A live audio webcast will also be available online at https://ir.teladoc.com/news-and-events/events-and-presentations/.
A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.
About Teladoc Health
Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at teladochealth.com.
Investors:
Michael Minchak
IR@teladochealth.com
617-444-9612
